[{"address1": "149 Fifth Avenue", "address2": "Suite 500", "city": "New York", "state": "NY", "zip": "10010", "country": "United States", "phone": "212 994 8200", "website": "https://www.protagenic.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.", "fullTimeEmployees": 1, "maxAge": 86400, "priceHint": 4, "previousClose": 0.99, "open": 1.005, "dayLow": 0.9101, "dayHigh": 1.005, "regularMarketPreviousClose": 0.99, "regularMarketOpen": 1.005, "regularMarketDayLow": 0.9101, "regularMarketDayHigh": 1.005, "beta": 0.319, "forwardPE": -1.724138, "volume": 16372, "regularMarketVolume": 16372, "averageVolume": 14885, "averageVolume10days": 12890, "averageDailyVolume10Day": 12890, "marketCap": 4452270, "fiftyTwoWeekLow": 0.68, "fiftyTwoWeekHigh": 2.22, "fiftyDayAverage": 1.31286, "twoHundredDayAverage": 1.149775, "currency": "USD", "enterpriseValue": 2011329, "floatShares": 3221103, "sharesOutstanding": 4452270, "sharesShort": 9729, "sharesShortPriorMonth": 9829, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0022, "heldPercentInsiders": 0.21831, "heldPercentInstitutions": 0.1753, "shortRatio": 1.36, "shortPercentOfFloat": 0.0028, "impliedSharesOutstanding": 4452270, "bookValue": 0.481, "priceToBook": 2.0790021, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -6006695, "trailingEps": -1.37, "forwardEps": -0.58, "lastSplitFactor": "1:4", "lastSplitDate": 1679529600, "enterpriseToEbitda": -0.367, "52WeekChange": -0.49494952, "SandP52WeekChange": 0.26238096, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "PTIX", "underlyingSymbol": "PTIX", "shortName": "Protagenic Therapeutics, Inc.", "longName": "Protagenic Therapeutics, Inc.", "firstTradeDateEpochUtc": 1619530200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "c39eb2ce-38b5-3b80-82ab-59608762cc06", "messageBoardId": "finmb_133204458", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.0, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 2423803, "totalCashPerShare": 0.547, "ebitda": -5485339, "quickRatio": 5.433, "currentRatio": 5.532, "returnOnAssets": -0.67425, "returnOnEquity": -1.4056, "freeCashflow": -3354484, "operatingCashflow": -4991127, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]